ofa tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves FDA says shortage of GLP-1
Description
[DOI] [PubMed] [Google Scholar] 71.Chen W.R., Chen Y.D., Tian F., Yang N., Cheng L.Q., Hu S.Y., Wang J., Yang J.J., Wang S.F., Gu X.F
![ofa tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves FDA says shortage of GLP-1](https://scx2.b-cdn.net/gfx/news/hires/2024/fda-says-shortage-of-g.jpg)
administered Subcutaneous injection (dosing interval not publicly specified) for 26-week weight-loss phase followed by 26-week maintenance phase
The effects of graded levels of calorie restriction: VI
![ofa tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves FDA says shortage of GLP-1](https://static01.nyt.com/images/2024/04/17/multimedia/17sleep-apnea-mfjq/17sleep-apnea-mfjq-articleLarge.jpg?quality=75&auto=webp&disable=upscale)
More research could help clarify the contribution of obesity to disease outcomes
![ofa tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves FDA says shortage of GLP-1](https://i.ytimg.com/vi/nSETJvjA3OM/sddefault.jpg)
The multifaceted contributions of mitochondria to cellular metabolism
![ofa tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves FDA says shortage of GLP-1](https://assets.medpagetoday.net/media/images/113xxx/113478.jpg?width=0.8)
Some reports suggest that the Wegovy pill performs about the same compared to the injection in terms of weight loss results
![ofa tirzepatide UPDATE [March 7, 2025]: takes case to appeals court as legal battle evolves FDA says shortage of GLP-1](https://assets.medpagetoday.net/media/images/113xxx/113220.jpg?width=0.8)